DOPAVISION
Dopavision is a therapeutic company developing a digital therapeutic for myopia. Myopia, or shortsightedness, is a condition where the visual image is focused in front of the retina, instead of on the retina itself, as it should. People with myopia have good near sight vision but poor distance vision. Dopavision is developing a digital therapeutic for myopia which can be seamlessly and invisibly integrated with the use of a smartphone. Myopia is a visual condition that affects on average every t... hird person globally, a share that has increased rapidly during the last two decades. The goal of the Berlin-based startup is to develop a clinically validated therapy for myopia progression in children and adolescents. The technology delivers light stimulation to specific photosensitive cells on the retina which in turn modulate dopamine, a neurotransmitter that is important for the regulation of eye growth. Founded in 2017, Dopavision GmbH is supported by the German government via the “Industrie-in-Klinik” program of the BMBF (Federal Ministry of Education and Research) with the amount of € 1.4 million over three years.
DOPAVISION
Social Links:
Industry:
Biotechnology Health Care Medical Device Therapeutics
Founded:
2017-01-01
Address:
Berlin, Berlin, Germany
Country:
Germany
Website Url:
http://www.dopavision.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
13.2 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome Global Site Tag
Similar Organizations
Kvatchii
Kvatchii is developing a truly patient-focused deep health digital platform from ground-up in India.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Current Advisors List
Current Employees Featured
Founder
Investors List
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund investment in Series A - Dopavision
Seventure Partners
Seventure Partners investment in Series A - Dopavision
Ababax.Health
Ababax.Health investment in Series A - Dopavision
dRx Capital
dRx Capital investment in Series A - Dopavision
Novartis Pharma
Novartis Pharma investment in Series A - Dopavision
Ralf Meister
Ralf Meister investment in Seed Round - Dopavision
Flyinghealth
Flyinghealth investment in Seed Round - Dopavision
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund investment in Seed Round - Dopavision
Key Employee Changes
| Date | New article |
|---|---|
| 2022-05-25 | Dopavision Appoints Mark S. Wuttke, Ph.D., as Chief Executive Officer |
Official Site Inspections
http://www.dopavision.com
- Host name: wp1.swpress.de
- IP address: 213.133.103.236
- Location: Nuremberg Germany
- Latitude: 49.4475
- Longitude: 11.0683
- Timezone: Europe/Berlin
- Postal: 90409
More informations about "Dopavision"
Dopavision - Crunchbase Company Profile & Funding
Dopavision is a therapeutic company developing a digital therapeutic for myopia. Myopia, or shortsightedness, is a condition where the visual image is focused …See details»
Dopavision 2025 Company Profile: Valuation, Funding & Investors
Dopavision General Information Description. Developer of a digital therapeutic technology designed to slow down myopia progression in children and adolescents. The company's …See details»
Dopavision - LinkedIn
Dopavision presented key data from its MyopiaX-1 clinical trial at the 19th International Myopia Conference in Sanya, China. Friday’s presentation, delivered by Prof. Ian Flitcroft, D.Phil ...See details»
Dopavision - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 28, 2025 Dopavision is a series A company based in Berlin (Germany), founded in 2017 by Hamed Bahmani and Stefan Zundel. It operates as a Developer of a digital therapeutic for …See details»
Our Team | Dopavision - Experts in Research and Innovation
We have built Dopavision to develop breakthrough healthcare solutions that are accessible and designed for everyday life. Our team combines scientific and technical curiosity with the goal …See details»
Dopavision - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jul 14, 2021: Series A - …See details»
Dopavision - The Org
The goal of the Berlin-based startup is to develop a clinically validated therapy for myopia progression in children and adolescents. The technology delivers light stimulation to specific …See details»
Dopavision Overview | SignalHire Company Profile
The position of the Managing Director is occupied by Hamed Bahmani. Its headquarters is located at Berlin, Berlin, DE. The number of employees ranges from 1 to 25. The annual revenue of …See details»
Dopavision's Leadership Team - Team members and org chart
Other teams at Dopavision. View all +1. Board of Directors. 4 members. CEO and Executive Team. 1 members. The Org helps you hire great candidates. It takes less than ten minutes to …See details»
Dopavision | VentureRadar
Dopavision is developing a digital therapeutic for myopia which can be seamlessly and invisibly integrated with the use of a smartphone. Myopia is a visual condition that affects on average …See details»
Dopavision Closes €12 Million Series A Round to Advance
Jul 14, 2021 Dopavision´s goal is to develop a clinically validated therapy to halt myopia progression in children and adolescents. Founded in 2017 by Hamed Bahmani, Dopavision …See details»
Dopavision Company Profile: Funding, Investors & Partnerships
Dopavision is pioneering the development of digital therapeutics in ophthalmology. The Berlin-based start-up is developing a digital therapeutic for childhood myopia which can be easily …See details»
Boehringer leads investment in digital therapy for myopia
Jun 21, 2019 Dr Hamed Bahmani, Dopavision’s co-founder, said: “Since the light stimulus in Dopavision’s approach is delivered from a digital device like a smartphone, it is truly a digital …See details»
Dopavision - Craft
Dopavision is a company that develops a digital therapeutic for myopia, which can be invisibly integrated with the use of a smartphone. Myopia, or shortsightedness, is a condition where the …See details»
Dopavision raises €12m for DTx to tackle myopia epidemic
Jul 19, 2021 Digital therapeutics (DTx) startup Dopavision has raised funding to develop its lead product, an app designed to slow the progression of myopia – or short-sightedness – in …See details»
dopavision (Dopavision GmbH) - Startbase
Offene Jobs bei dopavision: Weitere Startups in der Nähe von dopavision. Deep Maze Technologies. Startup 2021 Berlin. Deep Maze Technologies. Veritas Entertainment. Startup …See details»
Dopavision Company Information - Funding, Investors, and More
Get information on funding, investors, industries, and more for Dopavision. See Dopavision company profile and funding data.See details»
Dopavision sees success from early-stage Myopia app trial
May 28, 2024 Dopavision CEO Mark Wuttke said: “The six-month findings of the MyopiaX-1 trial mark a monumental achievement for Dopavision. With MyopiaX, our goal is to enrich myopia …See details»
David Paton, Creator of Flying Eye Hospital, Dies at 94
2 hours ago Now called Orbis International, the organization is on its third plane, an MD-10 donated by Federal Express. From 2014 to 2023, Orbis performed more than 621,000 …See details»
Dopavision - EU-Startups
Dopavision is pioneering the development of digital therapeutics in ophthalmology. The Berlin-based start-up is developing a digital therapeutic for childhood myopia which can be easily …See details»